Page last updated: 2024-10-30

metformin and Osteonecrosis

metformin has been researched along with Osteonecrosis in 3 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Osteonecrosis: Death of a bone or part of a bone, either atraumatic or posttraumatic.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Tang, B1
Chen, Y1
Zhao, P1
Yan, W1
Huang, X1
Jiang, W1
Sun, M1
Zhang, H1
Xiang, D1
Chen, T1
Lian, C1
Zhang, J1
Park, SH1
Kang, MA1
Moon, YJ1
Jang, KY1
Kim, JR1
Kotler, DP1

Other Studies

3 other studies available for metformin and Osteonecrosis

ArticleYear
MiR-601-induced BMSCs senescence accelerates steroid-induced osteonecrosis of the femoral head progression by targeting SIRT1.
    Cellular and molecular life sciences : CMLS, 2023, Aug-19, Volume: 80, Issue:9

    Topics: Animals; Femur Head; Glucocorticoids; Hydrogen Peroxide; Mesenchymal Stem Cells; Metformin; MicroRNA

2023
Metformin coordinates osteoblast/osteoclast differentiation associated with ischemic osteonecrosis.
    Aging, 2020, 02-11, Volume: 12, Issue:6

    Topics: Angiogenesis Inducing Agents; Angiopoietin-1; Animals; Cell Differentiation; Cell Line, Tumor; Femur

2020
Metabolic alterations in HIV lipodystrophy. IAPAC sessions 2001, July 18-19, 2001 - Chicago.
    IAPAC monthly, 2001, Volume: 7, Issue:8

    Topics: Acidosis; Anti-HIV Agents; Bone Diseases, Metabolic; Cost-Benefit Analysis; Glucose; Glucose Intoler

2001